Limonin inhibits the stemness of cancer stem-like cells derived from colorectal carcinoma cells potentially via blocking STAT3 signaling

Figure 4 Limonin inhibits malignancies in cancer stem-like cells derived from colorectal cancer cells. A: Cell invasion capacity was measured by performing transwell assay after being cultured with 10 or 20 μmol/L limonin; B: After limonin treatment, tumor formation in soft agar was performed. ^aP < 0.05 vs Mock group. CSCs: Cancer stem-like cells.